S'abonner

Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma - 24/12/11

Doi : 10.1016/j.jaci.2011.08.011 
Eleni Tsitsiou, PhD a, , Andrew E. Williams, PhD b, , Sterghios A. Moschos, PhD c, Ketan Patel, PhD c, Christos Rossios, PhD b, Xiaoying Jiang, PhD a, Oona-Delpuech Adams, PhD c, Patricia Macedo, MD b, Richard Booton, PhD a, David Gibeon, MD b, Kian Fan Chung, PhD b, Mark A. Lindsay, PhD a, b, d,
a Respiratory Research Group, Faculty of Medical and Human Sciences, University of Manchester, and the National Institute for Health Research Translational Research Facility in Respiratory Medicine, University Hospital of South Manchester, Manchester, United Kingdom 
b Airways Disease, National Heart and Lung Institute, Imperial College, London, and the Royal Brompton National Institute for Health Research Biomedical Research Unit, London, United Kingdom 
c Pfizer Global Research and Development, Sandwich, Kent, United Kingdom 
d Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom 

Corresponding author: Mark A. Lindsay, PhD, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY United Kingdom.

Abstract

Background

Although previous studies have implicated tissue CD4+ T cells in the development and maintenance of the inflammatory response in asthmatic patients, little is known about the role of CD8+ T cells. There is now accumulating evidence that microRNAs and other noncoding RNAs are important regulators of T-cell function.

Objectives

We sought to use transcriptomics to determine the activation state of circulating CD4+ and CD8+ T cells in patients with nonsevere and severe asthma.

Methods

mRNA and noncoding RNA expression in circulating T cells was measured by means of microarray, quantitative real-time PCR, or both.

Results

Comparison of mRNA expression showed widespread changes in the circulating CD8+ but not CD4+ T cells from patients with severe asthma. No changes were observed in the CD4+ and CD8+ T cells in patients with nonsevere asthma versus those in healthy control subjects. Bioinformatics analysis showed that the changes in CD8+ T-cell mRNA expression were associated with multiple pathways involved in T-cell activation. As with mRNAs, we also observed widespread changes in expression of noncoding RNA species, including natural antisense, pseudogenes, intronic long noncoding RNAs (lncRNAs), and intergenic lncRNAs in CD8+ T cells from patients with severe asthma. Measurement of the microRNA expression profile showed selective downregulation of miR-28-5p in CD8+ T cells and reduction of miR-146a and miR-146b in both CD4+ and CD8+ T cells.

Conclusions

Severe asthma is associated with the activation of circulating CD8+ T cells but not CD4+ T cells. This response is correlated with the downregulation of miR-146a/b and miR-28-5p, as well as changes in the expression of multiple species of lncRNA that might regulate CD8+ T-cell function.

Le texte complet de cet article est disponible en PDF.

Key words : Severe asthma, CD8+ T cells, transcriptome, long noncoding RNA, microRNA

Abbreviations used : FDR, LCN, lncRNA, miRNA, qRT-PCR, Treg


Plan


 Supported by a National Institute for Health Research (NIHR) Translational Research Facility Grant (to E.T. and R.B.), Asthma UK (07/015 to A.E.W.), the Wellcome Trust (076111 to M.A.L. and 085935 to K.F.C.), the NIHR Royal Brompton Respiratory Biomedical Research Unit (to K.F.C.), and a Chinese Overseas Study Scholarship (to X.J.).
 Disclosure of potential conflict of interest: S. A. Moschos has received travel grants from Miltenyi Biotech and Caliper Life Sciences. K. F. Chung is a consultant for Gilead, is on the advisory board for Merck and GlaxoSmithKline, and has received research support from the Medical Research Council UK, Asthma UK, and the Wellcome Trust. The rest of the authors have declared that they have no conflict of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129 - N° 1

P. 95-103 - janvier 2012 Retour au numéro
Article précédent Article précédent
  • Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo
  • Anthony Bosco, Samira Ehteshami, Sujatha Panyala, Fernando D. Martinez
| Article suivant Article suivant
  • Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
  • Aarti Shikotra, David F. Choy, Chandra M. Ohri, Emma Doran, Claire Butler, Beverley Hargadon, Maria Shelley, Alexander R. Abbas, Cary D. Austin, Janet Jackman, Lawren C. Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.